George Mason University breast cancer treatment patent licensed by Targeted Pharmaceuticals

(George Mason University) A patent granted to George Mason University Research Foundation Inc., via Drs. Virginia Espina and Lance Liotta of George Mason University, and Dr. Kirsten Edmiston of Inova Health System which describes a novel treatment method for pre-invasive breast cancer, has been exclusively licensed to Targeted Pharmaceuticals LLC, a clinical-stage biopharmaceutical company focused on utilizing cannabinoids for the treatment of oncology and central nervous system disorders.